Olimpia Farina
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease.
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease.
Journal: Neuromuscular disorders : NMD
Published: December 04, 2017
Successful long-term therapy with flecainide in a family with paramyotonia congenita.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: November 08, 2017
Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy.
Journal: Journal of cellular physiology
Published: October 17, 2017
Identification of the first dominant mutation of LAMA5 gene causing a complex multisystem syndrome due to dysfunction of the extracellular matrix.
Journal: Journal of medical genetics
Published: January 24, 2017
Symptomatic Heterozygosity due to Definite GAA Mutations in Late-Onset Pompe Disease.
Journal: Journal of neuromuscular diseases
Published: January 01, 2015
A Unique Myopathy Syndrome in a Patient Disclosing Clinical, Laboratory, and Genetic Findings of Late-Onset Pompe Disease, Together with a Lack of Dysferlin on Muscle Biopsy.
Journal: Journal of neuromuscular diseases
Published: January 01, 2015
Distinct disease phenotypes linked to different combinations of GAA mutations in a large late-onset GSDII sibship.
Journal: Orphanet journal of rare diseases
Published: July 04, 2013
Digenic mutational inheritance of the integrin alpha 7 and the myosin heavy chain 7B genes causes congenital myopathy with left ventricular non-compact cardiomyopathy.
Journal: Orphanet journal of rare diseases
Published: April 05, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026